Company Description
COILED THERAPEUTICS PLC (OTC Link: ROQAF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.5M.
ROQAF stock has gained 350.5% over the past year. Shares last traded at $0.0964.
This page provides a comprehensive overview of ROQAF stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
COILED THERAPEUTICS PLC (ROQAF) stock last traded at $0.0964. Over the past 12 months, the stock has gained 350.5%. At a market capitalization of $4.5M, ROQAF is classified as a micro-cap stock with approximately 425.9M shares outstanding.
Latest News
COILED THERAPEUTICS PLC has 1 recent news article. View all ROQAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in COILED THERAPEUTICS PLC (ROQAF) currently stands at 1.0 thousand shares, up 150.3% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for COILED THERAPEUTICS PLC (ROQAF) currently stands at 3.9 days, down 99.6% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 21.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ROQAF Company Profile & Sector Positioning
COILED THERAPEUTICS PLC (ROQAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ROQAF often look at related companies in the same sector, including UNIVERSAL IBOGAINE INC (IBOGF), DOSEOLOGY SCIENCES INC (DOSEF), BSF Enterprise PLC (BSFAF), ASEP MED HLDGS INC (SEPSF), and Core One Labs (CLABF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ROQAF's relative position within its industry.